FindTrial
Sign In

TMT quantitative proteomics analysis reveals differential proteins in herpes zoster

TMT quantitative proteomics analysis reveals differential proteins in herpes zoster

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018504
Enrollment
Unknown
Registered
2018-09-21
Start date
2018-10-03
Completion date
Unknown
Last updated
2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster

Interventions

Case series:Analgesic therapy

Sponsors

First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) grade I, II; somatic pain; hyperalgesia, such as touch pain; pain site along nerve distribution; blisters in the pain area.

Exclusion criteria

Exclusion criteria: Other systemic or local infections, such as fever; sympathetic or psychiatric disorders; drug or other physical therapy.

Design outcomes

Primary

MeasureTime frame
Pain score;TMT quantitative proteomics analysis reveals differential proteins;—

Countries

China

Contacts

Public ContactWang Tingting

First Hospital of Jiaxing

630547032@qq.com+86 15824363736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026